EGFR-targeted gadolinium contrast agents for enhanced molecular magnetic resonance imaging of tumors
Journal of Biological Chemistry · 2026-01 · 302 (1) · 110992
DOI: 10.1016/j.jbc.2025.110992 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2026-01. Verfasst von Mengyao Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China; …. Hauptthemen laut MEDLINE: Contrast Media, Gadolinium, ErbB Receptors, Magnetic Resonance Imaging. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: School of Life Sciences, University of Warwick, Wuhan University, National Natural Science Foundation of China.
Abstract (Originalsprache)
Magnetic resonance imaging (MRI) is a widely used tool for tumor diagnosis, but current contrast agents often lack sufficient sensitivity and specificity. To address these limitations, we developed novel gadolinium-based (Gd) contrast agents conjugated with epidermal growth factor receptor (EGFR)-binding peptides (EBPs) for targeted MRI of EGFR-overexpressing tumors. The synthesized EBP-Gd-DO3A and EBP-(Gd-DO3A)3 conjugates exhibited high binding affinity and specificity for EGFR-positive cells, as demonstrated through cell binding assays and fluorescence microscopy. Competitive binding assays confirmed EGFR-mediated specificity. In vitro MRI revealed strong contrast enhancement in EGFR-overexpressing tumor cells, while in vivo studies in xenograft models showed increased tumor uptake and prolonged contrast retention. These agents demonstrated superior specificity and sensitivity compared to traditional non-targeted Gd-DO3A, offering a promising approach for improved tumor detection, grading, and prognosis in clinical molecular imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Colorectal and Anal Surgery, Zhongnan Hospital of Wuhan University, School of Pharmaceutical Sciences, Wuhan University, Wuhan, China; Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Minis…
- Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Hubei Provincial Clinical Research Center for Precision Radiology & Interventional Medicine,…
Förderung
- School of Life Sciences, University of Warwick
- Wuhan University
- National Natural Science Foundation of China
- Imperial College London
Zitieren
APA
Chen, M., Chen, J., Ren, X., Liu, C., Bai, C., Wang, X., Duan, J., Ai, S., Yan, X., Yang, F., & Liu, X. (2026). EGFR-targeted gadolinium contrast agents for enhanced molecular magnetic resonance imaging of tumors. Journal of Biological Chemistry, 302(1), 110992. https://doi.org/10.1016/j.jbc.2025.110992
Vancouver
Chen M, Chen J, Ren X, Liu C, Bai C, Wang X, et al. EGFR-targeted gadolinium contrast agents for enhanced molecular magnetic resonance imaging of tumors. Journal of Biological Chemistry. 2026;302(1):110992. doi:10.1016/j.jbc.2025.110992
BibTeX
@article{Chen2026,
author = {Chen, Mengyao and Chen, Jing and Ren, Xue and Liu, Chunping and Bai, Chenwu and Wang, Xiaoya and Duan, Jianli and Ai, Shibin and Yan, Xinxin and Yang, Fan and Liu, Xin},
title = {EGFR-targeted gadolinium contrast agents for enhanced molecular magnetic resonance imaging of tumors},
journal = {Journal of Biological Chemistry},
year = {2026},
volume = {302},
number = {1},
pages = {110992},
doi = {10.1016/j.jbc.2025.110992}
}
EUVIMED